Indiana touts $16.5 million payout in latest opioid manufacturer settlement

LOUISVILLE, Ky. (WDRB) -- Indiana expects to receive $16.5 million from the latest multi-state opioid settlement with eight pharmaceutical manufacturers.

Attorney General Todd Rokita said in a news release Monday that this is the settlement with Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun and Zydus netted about $720 million. Some of the states involved will receive annual payments, while others will be paid in full.

"Thousands of Hoosiers have lost their lives as a result of the opioid crisis," Rokita said in a news release. "We can never undo that tragic loss of life, but we can hold accountable those responsible for contributing to the situations culminating in these deaths. That's what these settlements are all about, and I'm proud of the work of our team."

The terms of the settlement also say:

The companies are prohibited from engaging in the promotion of opioids or opioids products.
The companies cannot provide financial rewards or impose discipline on employees based on the volume of opioids sold.
The companies cannot manufacture, promote, or distribute any product containing more than 40 mg of oxycodone per pill and cannot in most circumstances offer discounts, coupons, or rebates for opioid products.
Finally, the companies cannot provide funding or grants to third parties for the promotion of opioid products and cannot engage in any lobbying activity related to opioids.

Since Rokita took office in January 2021, his office said Indiana has secured about $1.1 billion in similar settlements.

Floyds Knobs 12U softball team headed to Little League World Series

Coffee with Crawford | What sports (Oaks time change, a comeback) taught me last week